VirxSys' Series H Round

VirxSys raised a round of funding on April 18, 2011. Investors include OSV Currency Advisors.

VIRxSYS is a privately-held biotechnology company with proprietary platform technologies with which the Company intends to develop therapies for serious human diseases. The Company's platform technolo…

Articles about VirxSys' Series H Round: